Accelerating FemTech: Cohort 2
The Accelerating FemTech programme supports UK-based, early-stage companies, university spinouts, and entrepreneurial-minded academics focused on women’s health to gain the commercial and funding momentum they need for long-term success. It is delivered by the Health Innovation Network South London and national partners, utilising funding from Innovate UK (as part of the Biomedical Catalyst) in collaboration with the Medical Research Council.
Cohort 2 was delivered from November 2024 to March 2025, supporting 21 early-stage companies, university spinouts, and entrepreneurial academics. Building on the success of the first edition, the second edition provided a structured 10-week curriculum of workshops, personalised mentoring and high-impact networking opportunities. Learn more about the innovations below.
28X
Area of innovation: Menstruation
Technology: Digital platform
Description: 28X is a subscription-free menstrual app that provides clinical, personalised health content.
Website:
my28x.com
Jawsense
Area of innovation: Self-management
Technology: Medical device
Company description: Product 1: Smart Biofeedback Device: This wearable device addresses bruxism, a primary trigger for TMD, by predicting and mitigating episodes during sleep, delivers real-time, personalised neurostimulation to prevent these episodes. Product 2: Self-Management App.
Website:
jawsense.com
My Bliss
Area of innovation: Gynecology
Technology: Medical device
Description: Condoms to support vaginal microbiome.
Website:
my-bliss.co.uk
SIPS (Sickness in Pregnancy Support)
Area of innovation: Maternity
Technology: Digital platform
Description: A "one-stop shop" support service for women suffering from Nausea and vomiting in pregnancy (NVP) and Hyperemesis Gravidarum (HG).
LinkedIn:
SIPS
Umbi Health
Area of innovation: Personalised care
Technology: Digital platform
Description: Digital health platform providing comprehensive clinical care for women who have had a baby in the last 2 years. Addressing current needs and preventing longer term conditions, including hypertension and Type 2 diabetes.
Award: Most engaging pitch.
Website:
umbi.health
Aiatella
Area of innovation: Cardiovascular
Technology: Medical device
Description: An AI system which operates with existing medical imaging modalities (CT, MRI and Ultrasound) to preventatively screen women and underrepresented communities for cardiovascular risk.
Website:
aiatella.com
IVF Micro
Area of innovation: Fertility
Technology: Medical device
Description: IVFmicro is a device for supporting development of cell or tissue derived from an ovary, aiming to inprove embryo development success.
Website:
ivfmicro.com
Ove Care
Area of innovation: Gynecology
Technology: Digital platform
Description: Mobile app designed to guide girls aged 11-14 through the challenges of puberty, offering essential knowledge, support, and resources.
Website:
ovecare.com
SimLevator
Company area of innovation: Gynaecology
Technology: Device (not medical)
Description: Simulation learning tool for pelvic floor muscle contractions.
Website:
simlevator.com
Unravel Health
Area of innovation: Personalised care
Technology: Medical device
Description: Real time hormone level device using a saliva swab, helping manage conditions such as Perimenopause and PCOS.
Website:
unravel.health
EMM Technology
Area of innovation: Gynaecology
Technology: Medical device
Description: Emms cup collects bloodflow and automates measurement in menstrual cycles for women or clinicians.
Website:
emm.co
Level Zero Health Limited
Area of innovation: Self-management
Technology: Medical device
Description: Minimally invasive, wearable hormone monitoring device for women's health. The device uses novel aptamer-based sensor technologies to measure target molecules involved in the well being of women (estradiol, progesterone etc.) in interstitial fluid (ISF).
Website:
levelzerohealth.com
Papcup
Area of innovation: Gynaecology
Technology: Medical device
Description: At-home cervical screening device that detects cancer-causing HPV in menstrual blood. The device allows women to self-collect menstrual blood samples using any period product, such as pads or tampons.
Award: Innovation with the greatest potential benefit to patients.
Website:
papcup.co.uk
Taahirah
Area of innovation: Menstruation
Technology: Digital platform
Description: The Taahirah app is a holistic, menstrual health app integrating faith-aligned guidance with health insights through data tracking.
Website:
taahirah.health
Upskill
Area of innovation: Maternity
Technology: Digital platform
Description: A mobile/virtual reality (VR)-based, micro-learning platform that delivers training for NHS maternity staff.
Website:
upskill.health
Freeda AI
Area of innovation: Menopause
Technology: Digital platform
Description: An AI-driven digital menopause platform to tackle menopause symptoms from the start of the menopause pathway, providing AI-powered educational support, menopause assessment, and real-time guidance for self-care.
Website:
freeda.ai
Megi Health
Area of innovation: Cardiovascular
Technology: Digital platform
Description: Megi.ai uses artificial intelligence to support early detection and diagnostics in women's health conditions, improving clinical decision making.
Website:
megi.ai
Peripear Ltd
Company area of innovation: Maternity
Technology: Medical device
Description: Peripear is a simple-to-use, warm, stretchable compress comfortably fitted to the perineum, delivering support during the second stage of labour.
Award: Most potential to be revolutionary for women's health in the UK.
Website:
peri-pear.com
Tecrea
Area of innovation: UTI
Technology: Pharmaceutical
Description: Nanocin technology offers a novel, non-antibiotic approach against recurrent UTIs.
Website:
tecrea.com
UXClinician - Get Out Get Love
Area of innovation: Domestic Abuse
Technology: Digital platform
Description: An app/desktop-based programme that offers self-delivered, self-paced recovery for women at work experiencing domestic abuse.
Website:
getoutgetlove.com
Learn more about Accelerating FemTech
Read the full evaluation to learn how we've supported innovators focused on women’s health.
Read more